Altered Expression of PTEN and Its Major Regulator MicroRNA-21 in Pulmonary Neuroendocrine Tumors

Overview

Journal Korean J Pathol

Specialty Pathology

Date 2014 Mar 15

PMID 24627690

Citations 5

Authors

Hyoun Wook Lee

Seung Yeon Ha

Mee Sook Roh

Affiliations

Soon will be listed here.

Abstract

Background: Phosphatase and tensin homolog on chromosome ten (PTEN) is one of the most frequently inactivated tumor suppressors in various tumor types. MicroRNA-21 (miR-21) may affect tumor progression by post-transcriptional repression of expression of tumor suppressors, such as PTEN. This study was conducted to evaluate the significance of PTEN expression in pulmonary neuroendocrine (NE) tumors and to analyze the relationship between PTEN and miR-21 expressions.

Methods: Expressions of PTEN and miR-21 were investigated by immunohistochemistry and real time reverse transcription-polymerase chain reaction, respectively, in 75 resected pulmonary NE tumors (23 typical carcinoids [TCs], nine atypical carcinoids [ACs], 22 large cell NE carcinomas [LCNECs], and 21 small cell lung carcinomas [SCLCs]).

Results: Loss of PTEN expression was observed in four of 23 TCs (17.4%), four of nine ACs (44.4%), 16 of 22 LCNECs (72.7%) and nine of 21 SCLCs (42.9%) (p=.025). The expression level of miR-21 was significantly higher in high-grade NE carcinomas than in carcinoid tumors (p<.001). PTEN expression was inversely correlated with miR-21 expression (p<.001).

Conclusions: This study suggests that aberrant expression of PTEN in relation to miR-21 may represent an important step in the development and progression of pulmonary NE tumors.

Citing Articles

Neuroendocrine Tumors Are Enriched in Cowden Syndrome.

Greidinger A, Miller-Samuel S, Giri V, Sue-Ann Woo M, Akumalla S, Zeigler-Johnson C JCO Precis Oncol. 2020; 4.

PMID: 32923874 PMC: 7446357. DOI: 10.1200/PO.19.00241.

The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors.

Chang T, Shan Y, Chu P, Jiang S, Hung W, Chen Y Oncotarget. 2017; 8(58):98068-98083.

PMID: 29228674 PMC: 5716714. DOI: 10.18632/oncotarget.20956.

Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.

Gajate P, Alonso-Gordoa T, Martinez-Saez O, Molina-Cerrillo J, Grande E Clin Transl Oncol. 2017; 20(5):561-569.

PMID: 29124519 DOI: 10.1007/s12094-017-1758-3.

Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung.

Demes M, Aszyk C, Bartsch H, Schirren J, Fisseler-Eckhoff A Cancers (Basel). 2016; 8(4).

PMID: 27023611 PMC: 4846847. DOI: 10.3390/cancers8040038.

Pulmonary atypical carcinoid in a patient with Cowden syndrome.

Tsunezuka H, Abe K, Shimada J, Inoue M Interact Cardiovasc Thorac Surg. 2016; 22(6):860-2.

PMID: 26932665 PMC: 4986790. DOI: 10.1093/icvts/ivw046.

References

Swarts D, Ramaekers F, Speel E . Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochim Biophys Acta. 2012; 1826(2):255-71. DOI: 10.1016/j.bbcan.2012.05.001. View

Choi C, Kim K, Song J, Choi S, Kim L, Park I . Construction of high-density tissue microarrays at low cost by using self-made manual microarray kits and recipient paraffin blocks. Korean J Pathol. 2013; 46(6):562-8. PMC: 3540334. DOI: 10.4132/KoreanJPathol.2012.46.6.562. View

Fei J, Lan F, Guo M, Li Y, Liu Y . Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth. J Drug Target. 2008; 16(9):688-93. DOI: 10.1080/10611860802295946. View

Marsit C, Zheng S, Aldape K, Hinds P, Nelson H, Wiencke J . PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol. 2005; 36(7):768-76. DOI: 10.1016/j.humpath.2005.05.006. View

Gregory R, Shiekhattar R . MicroRNA biogenesis and cancer. Cancer Res. 2005; 65(9):3509-12. DOI: 10.1158/0008-5472.CAN-05-0298. View

Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S . MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2007; 27(15):2128-36. DOI: 10.1038/sj.onc.1210856. View

Zhang B, Li J, Yu B, Zhu Z, Liu B, Yan M . microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012; 27(4):1019-26. PMC: 3583594. DOI: 10.3892/or.2012.1645. View

Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob S, Patel T . MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007; 133(2):647-58. PMC: 4285346. DOI: 10.1053/j.gastro.2007.05.022. View

Tachibana M, Shibakita M, Ohno S, Kinugasa S, Yoshimura H, Ueda S . Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer. 2002; 94(7):1955-60. DOI: 10.1002/cncr.0678. View

10.

Markou A, Tsaroucha E, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou E . Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem. 2008; 54(10):1696-704. DOI: 10.1373/clinchem.2007.101741. View

11.

Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada K . Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 1998; 280(5369):1614-7. DOI: 10.1126/science.280.5369.1614. View

12.

Gabriely G, Wurdinger T, Kesari S, Esau C, Burchard J, Linsley P . MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008; 28(17):5369-80. PMC: 2519720. DOI: 10.1128/MCB.00479-08. View

13.

Xiong B, Cheng Y, Ma L, Zhang C . MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol. 2012; 42(1):219-28. DOI: 10.3892/ijo.2012.1707. View

14.

Depowski P, Rosenthal S, Ross J . Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol. 2001; 14(7):672-6. DOI: 10.1038/modpathol.3880371. View

15.

Stambolic V, Suzuki A, de la Pompa J, Brothers G, Mirtsos C, Sasaki T . Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998; 95(1):29-39. DOI: 10.1016/s0092-8674(00)81780-8. View

16.

Maehama T, Dixon J . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273(22):13375-8. DOI: 10.1074/jbc.273.22.13375. View

17.

Zhu X, Qin X, Fei M, Hou W, Greshock J, Bachman K . Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma. Exp Ther Med. 2012; 5(1):57-64. PMC: 3524019. DOI: 10.3892/etm.2012.749. View

18.

Ahn S, Hwangbo W, Kim H, Kim C . Naked cuticle Drosophila 1 expression in histologic subtypes of small adenocarcinoma of the lung. Korean J Pathol. 2013; 47(3):211-8. PMC: 3701816. DOI: 10.4132/KoreanJPathol.2013.47.3.211. View

19.

Lee H, Lee E, Ha S, Lee C, Chang H, Chang S . Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors. Pathol Int. 2012; 62(9):583-91. DOI: 10.1111/j.1440-1827.2012.02845.x. View

20.

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View